FDA Clearance Tracker · P150037
CyPass Micro-Stent
Last checked: Nov 19, 2026Latest source record: Jul 29, 2016 (this decision)Source: openFDAMethods & limitations
Decided
Jul 29, 2016
Approval withdrawn
Time to decision
282 days
Received Oct 21, 2015. Calendar days, including time FDA spent waiting on the applicant.
Pathway
PMA
Device class
Class III
The decision
- FDA number
- P150037
- Device name
- CyPass Micro-Stent
- Applicant
- Alcon Research, Ltd.
- Applicant location
- Fort Worth, TX
- Received
- Oct 21, 2015
- Decided
- Jul 29, 2016
- Decision
- Approval withdrawn
- Supplements
- 12 in FDA's data for this PMA. See them on the FDA record
Device type
- Device type
- Intraocular pressure lowering implant (OGO)
- Device class
- Class III
- Specialty
- Ophthalmology
FDA's approval statement
As written in FDA's record.
Approval for the CyPass® System, Model 241-S. This device is indicated for use in conjunction with cataract surgery for the reduction of intraocular pressure (IOP) in adult patients with mild to moderate primary open-angle glaucoma (POAG).
How new is this?
These are facts about FDA's records. They are not a judgment about the device.
- It is not the first decision under product code OGO. The earliest in FDA's data is P000026, decided Jul 12, 2001.
- It is not on FDA's public list of Breakthrough Devices with marketing authorization (list dated June 30, 2026). FDA does not publish which devices hold the designation before they are authorized, and the list is updated only a few times a year.
Source documents
Other decisions for Alcon Research, Ltd.
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
- AcrySof IQ PanOptix Trifocal Intraocular Lens and AcrySof IQ PanOptix Toric Trifocal Intraocular LensPMA supplement
P040020-S087 · Decided Aug 26, 2019 · 207 days after receipt · Panel Track
Device type: Lens, multifocal intraocular (MFK) · Ophthalmology
K161794 · Decided Apr 14, 2017 · 288 days after receipt
Device type: Unit, Phacofragmentation (HQC) · Ophthalmology
- HyperVit Vitrectomy Probe, 23 GA, HyperVit Vitrectomy Probe, 25+, HyperVit Vitrectomy Probe, 27+510(k)
K170520 · Decided Mar 22, 2017 · 28 days after receipt
Device type: Vitrectomy, Instrument Cutter (MLZ) · Ophthalmology
2 more FDA decisions with a free account
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.